We previously reported that 17b-estradiol (E2) is pronociceptive in a visceral pain model in the rat. Subcutaneously (s.c.) administered E2 reversed the decrease in the colorectal distention (CRD)-evoked visceromotor response produced by ovariectomy (OVx) and CRD-induced nociceptive responses were greater in proestrous rats compared with met/diestrous rats. The site of action, the type of estrogen receptors activated, and the possible intracellular signaling pathway involved are yet to be established. In the present study, intrathecal (i.t.) E2 administered to OVx rats mimicked the effects of s.c. E2, suggesting that spinal estrogen receptors are involved. This is further supported by the observations that the antiestrogen ICI 182,780 injected i.t. in intact female rats significantly decreased the visceromotor response to CRD, the response of colonic afferents was not affected by OVx, and colonic afferents did not label for estrogen receptor a (ERa). The ERa selective agonist, 4,4 0 ,4 00 -[4-propyl-(1H)-pyrazole-1,3,5-triyl]tris-phenol (PPT; s.c. or i.t.) facilitated the visceromotor response similar to E2, suggesting ERa activation is involved in mediating the pronociceptive effect of E2. PPT (s.c. or i.t.) increased the response of spinal dorsal horn neurons to CRD, indicating a spinal site of action. In addition, s.c. E2 or PPT increased CRDinduced spinal extracellular signal-regulated kinase (ERK) phosphorylation that was not observed in OVx rats and a mitogen-activated protein kinase (MAPK) kinase (MEK) inhibitor blocked facilitation of the visceromotor response by PPT. Taken together, the present study demonstrates that spinal ERa mediates the pronociceptive effect of E2 on visceral signal processing through activation of the MAPK pathway.
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Introduction
The role of estrogens in nociceptive processing is unclear. Many studies suggest that an increase in plasma or local estrogen levels parallel an increase in nociceptive sensitivity [3,7,8,13,21, 41,47,63]. Consistent with these observations, our previous studies showed the response to colorectal distention (CRD) is greater in rats in proestrus compared with diestrus, and short-term ovariectomy (<3 weeks) decreases sensitivity to CRD that is reversed by systemically administrated estradiol (E2) [34] [35] [36] . In contrast, long-term loss of gonadal hormones by ovariectomy (at least 6 weeks) produced somatic and visceral hyperalgesia that was reversed by E2 replacement and E2 is antinociceptive in some somatic pain tests [51, 66, 67, 73] .
The classical estrogen receptors alpha (ERa) and beta (ERb) are nuclear receptors. Activation of both receptors initiates transcriptional changes through direct or indirect interaction with promoters of target genes modulating cellular function on a time scale of hours to days [18, 52] . E2 also elicits rapid effects via membrane bound receptors by triggering rapid activation of intracellular signaling transduction pathways including PLC/IP3, PI3K/AKT, and MAPK (ERK, JNK, and p38), which modulate receptor function, gene expression, and cell proliferation [11, 33, 46 ERa and ERb are both expressed in the peripheral nervous system, spinal cord, and supraspinal sites [20, 58, 69, 74, [81] [82] [83] . In the spinal cord, ERa is expressed predominantly in the superficial dorsal horn, localized to modulate nociceptive processing. ERb is denser in deeper laminae, suggesting a differential role of these receptors in nociceptive processing. However, there is no clear consensus as to the relative contribution of the different ERs to nociceptive processing.
